NANOBIOTIX (NANO.PA)

FR0011341205 - Common Stock

8.12  +0.32 (+4.1%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2020 2021 2022 2023 2024 2025 2026
Revenue
50K
-26.47%		10K
-80.00%		41.035M
EBITDA
-34.674M
22.97%		-51.019M
-47.14%		-45.202M
11.40%		-51M
-12.83%		N/A
EBIT
-36.428M
22.13%		-52.579M
-44.34%		-46.702M
11.18%		-21.581M
53.79%		N/A
Operating Margin
-72,856.00%-525,790.00%N/A-52.59%N/A
EPS
-1.40
40.43%		-1.35
3.57%		N/A-0.90

All data in EUR


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q2 / 23 Q4 / 23 Q2 / 24 Q4 / 24
EPS
Revenue
EBITDAN/AN/AN/AN/A
EBITN/AN/A

All data in EUR


EPS and Revenue Surprises


Recent Earnings VS Estimates (EUR)
Period Reported Estimate Difference Surprise Q2 2022 -0.76 -0.71 -0.05-6.44% Q4 2021 -0.47 -0.71 0.2434.17% Q2 2021 -0.88 -0.66 -0.22-32.73% Q4 2020 -0.49 -0.78 0.2936.79% Q2 2020 -0.91 -1.12 0.2118.89% Q4 2019 -1.20 -0.98 -0.22-22.98% Q2 2019 -1.15 -0.98 -0.17-17.44% Q4 2018 -0.91 -0.67 -0.24-35.18%
Recent Revenue VS Estimates (EUR)
Period Reported Estimate Difference Surprise Q2 2022 1.02K -1.02K-100.00% Q4 2021 1.02K -1.02K-100.00% Q2 2021 10K 1.071K 8.929K833.71% Q4 2020 13K 2.04M -2.027M-99.36% Q2 2020 40K 2.04M -2M-98.04% Q4 2019 31K 2.011M -1.98M-98.46% Q2 2019 37K 1.78M -1.743M-97.92% Q4 2018 40K 2.244M -2.204M-98.22%

EPS and Revenue Revisions


Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 6.35% 36.04%
RevenueN/A N/A -19.84% 1509.22%